- Report
- February 2026
- 469 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 385 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 280 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 290 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 297 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 364 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 367 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 216 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 296 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 478 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 287 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 280 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 294 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 204 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 281 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 477 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 277 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 381 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 459 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 280 Pages
Global
From €5103EUR$5,850USD£4,444GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more